BioPharm Reports (VennBio Ltd.), Jan 2011, Pages: 195
This report provides a comprehensive and up-to-date review of breastcancer biomarkers. Recent years have seen the discovery of significant numbers of new biomarkers and clinical data are now
Expert Reviews Ltd, May 2011, Pages: 202
This Special Focus Issue of the peer-reviewed journal Expert Review of Endocrinology and Metabolism brings together experts in the fields of hormone dependent- breast and prostate cancer
BioPharm Reports (VennBio Ltd.), Feb 2011, Pages: 95
The breastcancer immunotherapy pipeline is showing rapid development. This report presents findings on more than 30 candidate therapies, including 22 therapeutic vaccines and 11 antibodies
Koncept Analytics, June 2011, Pages: 39
Breastcancer is one of the most common types of cancer after lung cancer and the second leading cause of death in women. Globally, more than one million women are diagnosed with breastcancer
Datamonitor, Dec 2010, Pages: 34
Breastcancer will continue to be a major cancer among women in the seven major healthcare markets during the forecast period. The number of incident breastcancer cases will increase substantially
Bioseeker, Feb 2011
"Analytical Tool - BreastCancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breastcancer R&D and business development. It is at the same
Bioseeker, July 2011, Pages: 2895
This triple analysis focuses on cancer drug development strategies in both BreastCancer and Lung Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts
Bioseeker, March 2011, Pages: 2628
This triple analysis focuses on cancer drug development strategies in both BreastCancer and Colorectal Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual
Bioseeker, Oct 2010, Pages: 2182
This triple analysis focuses on cancer drug development strategies in both BreastCancer and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual
Bioseeker, Oct 2010, Pages: 2410
This triple analysis focuses on cancer drug development strategies in both BreastCancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual
Bioseeker, July 2011, Pages: 3292
This triple analysis focuses on cancer drug development strategies in BreastCancer, Colorectal Cancer and Lung Cancer. Each of these three individual parts is evaluated according to standardized
Bioseeker, July 2011, Pages: 2846
This triple analysis focuses on cancer drug development strategies in BreastCancer, Lung Cancer and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized
Bioseeker, July 2011, Pages: 3074
This triple analysis focuses on cancer drug development strategies in BreastCancer, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized
Bioseeker, March 2011, Pages: 2579
This triple analysis focuses on cancer drug development strategies in BreastCancer, Colorectal Cancer and Pancreatic Cancer. Each of these three individual parts is evaluated according
Bioseeker, March 2011, Pages: 2807
This triple analysis focuses on cancer drug development strategies in BreastCancer, Colorectal Cancer and Prostate Cancer. Each of these three individual parts is evaluated according
Bioseeker, May 2010, Pages: 2361
This triple analysis focuses on cancer drug development strategies in BreastCancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according
Bioseeker, Sep 2011, Pages: 3516
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (BreastCancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific
Bioseeker, Nov 2011, Pages: 2478
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (BreastCancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific
Bioseeker, Dec 2011, Pages: 3189
This triple analysis focuses on cancer drug development strategies in BreastCancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual
Bioseeker, Jan 2012, Pages: 3276
This triple analysis focuses on cancer drug development strategies in BreastCancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three individual